336 related articles for article (PubMed ID: 20679887)
41. Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial.
de Boer RH; Smith IE; Pastorino U; O'Brien ME; Ramage F; Ashley S; Goldstraw P
Br J Cancer; 1999 Mar; 79(9-10):1514-8. PubMed ID: 10188899
[TBL] [Abstract][Full Text] [Related]
42. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
[TBL] [Abstract][Full Text] [Related]
43. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
44. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.
Berghmans T; Paesmans M; Meert AP; Mascaux C; Lothaire P; Lafitte JJ; Sculier JP
Lung Cancer; 2005 Jul; 49(1):13-23. PubMed ID: 15949586
[TBL] [Abstract][Full Text] [Related]
45. Adjuvant chemotherapy for non-small-cell lung cancer.
Pisters KM
Clin Adv Hematol Oncol; 2003 Sep; 1(9):533-7. PubMed ID: 16258445
[TBL] [Abstract][Full Text] [Related]
46. [Lung cancer].
Nakagawa K; Kondo H
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1412-5. PubMed ID: 21918337
[TBL] [Abstract][Full Text] [Related]
47. Role of adjuvant chemotherapy in NSCLC (stages I to III).
Coleman MH; Bueno R
Surg Oncol Clin N Am; 2011 Oct; 20(4):757-67. PubMed ID: 21986270
[TBL] [Abstract][Full Text] [Related]
48. [Neoadjuvant chemotherapy in non small cell lung cancer].
Besse B; Vignot S; Le Chevalier T
Bull Cancer; 2006 Nov; 93(11):1087-92. PubMed ID: 17145577
[TBL] [Abstract][Full Text] [Related]
49. Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.
Douillard JY; Tribodet H; Aubert D; Shepherd FA; Rosell R; Ding K; Veillard AS; Seymour L; Le Chevalier T; Spiro S; Stephens R; Pignon JP;
J Thorac Oncol; 2010 Feb; 5(2):220-8. PubMed ID: 20027124
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant chemotherapy for non-small cell lung cancer.
Bria E; Cuppone F; Cecere FL; Milella M; Nisticò C; Cognetti F; Terzoli E
J Thorac Oncol; 2007 May; 2(5 Suppl):S7-11. PubMed ID: 17457237
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
Suehisa H; Toyooka S
Acta Med Okayama; 2009 Oct; 63(5):223-30. PubMed ID: 19893597
[TBL] [Abstract][Full Text] [Related]
52. Adjuvant therapy of resected non-small-cell lung cancer.
Socinski MA
Clin Lung Cancer; 2004 Nov; 6(3):162-9. PubMed ID: 15555217
[TBL] [Abstract][Full Text] [Related]
53. [Current status of postoperative adjuvant chemotherapy for completely resected non-small lung cancer].
Tsuboi M
Nihon Geka Gakkai Zasshi; 2014 May; 115(3):125-9. PubMed ID: 24946518
[TBL] [Abstract][Full Text] [Related]
54. The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer.
Horn L; Sandler AB; Putnam JB; Johnson DH
J Thorac Oncol; 2007 May; 2(5):377-83. PubMed ID: 17473651
[TBL] [Abstract][Full Text] [Related]
55. Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer.
Kato H; Tsuboi M; Kato Y; Ikeda N; Okunaka T; Hamada C
Int J Clin Oncol; 2005 Jun; 10(3):157-64. PubMed ID: 15990962
[TBL] [Abstract][Full Text] [Related]
56. Treatment Patterns and Health Resource Utilization Among Patients Diagnosed With Early Stage Resected Non-Small Cell Lung Cancer at US Community Oncology Practices.
Buck PO; Saverno KR; Miller PJ; Arondekar B; Walker MS
Clin Lung Cancer; 2015 Nov; 16(6):486-95. PubMed ID: 25681298
[TBL] [Abstract][Full Text] [Related]
57. Uptake and tolerance of adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada.
Winget M; Fleming J; Li X; Gao Z; Butts C
Lung Cancer; 2011 Apr; 72(1):52-8. PubMed ID: 20708293
[TBL] [Abstract][Full Text] [Related]
58. Individualized adjuvant chemotherapy for surgically resected lung cancer and the roles of biomarkers.
Ikeda N; Nagase S; Ohira T
Ann Thorac Cardiovasc Surg; 2009 Jun; 15(3):144-9. PubMed ID: 19597387
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant chemotherapy for resected non-small-cell lung cancer.
Solomon B; Mitchell JD; Bunn PA
Oncology (Williston Park); 2005 Nov; 19(13):1685-97; discussion 1698-700, 1705. PubMed ID: 16425522
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant treatment of resected lung cancer.
Chhatwani L; Cabebe E; Wakelee HA
Proc Am Thorac Soc; 2009 Apr; 6(2):194-200. PubMed ID: 19349488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]